Literature DB >> 11524637

Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation.

W O Suddath1, Y Deychak, P J Varghese.   

Abstract

STUDY
OBJECTIVE: Even though epinephrine has been shown to decrease the electrical stability of the heart, it is used extensively in cardiac resuscitation. The objective of this study is to document electrophysiologic parameters of epinephrine, which would facilitate defibrillation.
METHODS: In 20 swine, electrically induced ventricular fibrillation was allowed to continue for 10 minutes. Animals were then randomly assigned to receive either intracardiac injection of 1 mg of epinephrine or 10 mL of normal saline solution. Synchronization and dispersion of the repolarization of fibrillatory waves and cycle length were measured.
RESULTS: As the ventricular fibrillation continued, cycle length was prolonged, and synchronization and dispersion deteriorated. With epinephrine, cycle length shortened from 416+/-21 to 204+/-23 ms (P<.005), synchronization improved from 114+/-13 to 61+/-10 ms (P<.05), and dispersion narrowed from 84+/-10 to 49+/-8 ms (P<.005). Normal saline solution had no effect. Successful resuscitation was achieved in all 10 animals administered epinephrine and only 1 animal in the saline solution group.
CONCLUSION: Epinephrine's effect on cycle length, synchronization, and dispersion of repolarization of fibrillatory waves may be the mechanism with which it facilitates defibrillation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524637     DOI: 10.1067/mem.2001.115540

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  4 in total

Review 1.  Athletes with Implantable Cardioverter Defibrillators.

Authors:  Shiva P Ponamgi; Christopher V DeSimone; Michael J Ackerman
Journal:  Clin Sports Med       Date:  2015-07       Impact factor: 2.182

2.  Sports participation in patients with implantable cardioverter-defibrillators.

Authors:  R Lampert; B Olshansky
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-06

3.  The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variability.

Authors:  Bokyung Min; Jeffrey Kluger; James S Kalus; Danette Guertin; Brian F McBride; C Michael White
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-07       Impact factor: 1.468

Review 4.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.